CYP2C19
Protein sy'n cael ei godio yn y corff dynol gan y genyn CYP2C19 yw CYP2C19 a elwir hefyd yn Cytochrome P450 family 2 subfamily C member 19 (Saesneg). Segment o DNA yw'r genyn, sy'n amgodio ffwythiant arbennig. Mae'r genyn yma wedi ei leoli ar yr edefyn blaen o gromosom dynol 10, band 10q23.33.[2]
Cyfystyron[golygu | golygu cod]
Yn aml mae gan enynnau lawer o gyfystyron. Mae hyn oherwydd eu bod yn aml yn cael eu darganfod gan nifer o bobl mewn cyd-destunau gwahanol heb wybod mai'r un genynnau oeddyn nhw. Hefyd mae gan wahanol gymunedau gwyddonol safonau gwahanol ar gyfer enwi genynnau. Dyma restr o gyfystyron ar gyfer y genyn CYP2C19.
- CPCJ
- CYP2C
- P450C2C
- CYPIIC17
- CYPIIC19
- P450IIC19
Llyfryddiaeth[golygu | golygu cod]
- "[Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy]. ". Ter Arkh. 2017. PMID 28631703.
- "Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers. ". J Korean Med Sci. 2017. PMID 28378544.
- "Administration of Ticagrelor and Double-Dose Clopidogrel Based on Platelet Reactivity Determined by VerifyNow-P2Y12 for Chinese Subjects After Elective PCI. ". Int Heart J. 2017. PMID 28321022.
- "Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With CYP2C19Genetic Variants. ". Stroke. 2017. PMID 28289237.
- "Characterization of Three CYP2C19 Gene Variants by MassARRAY and Point of Care Techniques: Experience from a Czech Centre.". Arch Immunol Ther Exp (Warsz). 2016. PMID 28083610.